Global STD Diagnostics Market is
expected to reach USD 200.9 billion by 2022 according to a new study by Grand
View Research Inc. The rising geriatric population base, increasing global
incidence of various STIs, rise in sedentary lifestyle adoption levels, and
rising awareness & patient education are the driving forces for the STD
diagnostics market growth over the forecast period.
Increasing number of people having multiple
partners and low levels of infection awareness levels are the major drivers
fueling industrial growth. Increasing demand for rapid and accurate diagnostic
tests and presence of favorable government initiatives for STD testing in developing
countries such as Brazil, India, and China are further estimated to boost
market growth.
Further key findings from the study suggest:
·
Chlamydia testing accounted for over 34% of
the market in 2014. Chlamydia testing for sexually active women aged below 25
years is strictly recommended by the U.S Preventive Services Task Force (PSTF).
Syphilis testing is estimated to witness lucrative growth over the forecast
period. It is anticipated to grow at a CAGR of 10% owing to increasing
prevalence of syphilis infection globally.
·
On the basis of test location, laboratory
testing held the largest market share of over 63% in 2014 owing to the
availability of cost effective diagnostic tests used for multiple STIs at a
single location such as public health labs. Point of care on the other hand is
anticipated to be the fastest growing segment over the forecast period owing to
the owing to the introduction of CLIA waived tests
·
Laboratory testing devices dominated the
market in 2014 with revenue generation of over 67.0 billion.
Immunochromatographic assays were most preferred devices for STD diagnosis in
laboratory with revenue share of over 26%. Increasing technological
advancements are estimated to enhance usage rates of thermal cyclers over the
forecast period.
·
Portable/bench top or rapid diagnostic kits
are estimated to gain demand over the forecast period owing to features such as
user-friendliness, increasing awareness pertaining to self testing, and fast
results.
·
North America held the largest share of the
STD diagnostics market with revenue generation of over 32 billion in 2014. Introduction
of technologically advanced diagnostics techniques such as
immunochromatographic device by Chembio Diagnostics Systems Inc. is the major
factor attributing for its largest market share.
·
Asia Pacific region is estimated to witness
significant growth over the forecast period owing to the presence of high
amount of target population, rising awareness levels for STIs, and increasing
government initiatives and rise in disposable income expenditure levels. Asia
Pacific is expected to show double digit CAGR growth over the forecast period.
·
Major companies of the STD diagnostics
industry include Roche Holdings AG, Abbott Laboratories, Becton Dickinson and
Company, Hologic Inc., Danaher Corporation, Affymetrix, BioMerieux, Cepheid
Inc., Alere Inc., DiaSorin, and Orasure
·
Licensing and partnership deal making
activities in the molecular diagnostics sector are growing significantly in
terms of value. New entrants such as life science research groups, financial
investors, clinical laboratories, and medical technology players drive up the
values.
Browse Details of Report
@ http://www.grandviewresearch.com/industry-analysis/diagnostic-testing-of-stds-market
Grand
View Research has segmented the global STD diagnostics market on the basis of
product and region:
Global STD
Diagnostics Type Outlook (Revenue, USD Billion, 2012 - 2022)
·
Chlamydia
testing
·
Syphilis
testing
·
Gonorrhea
testing
·
Herpes
Simplex Virus testing
·
Human
Papilloma Virus testing
·
Human
Immunodeficiency Virus testing
·
Chancroid
testing
·
Others
Global STD
Diagnostics Location of Testing Outlook (Revenue, USD Billion, 2012 - 2022)
·
Laboratory
Testing
o
Commercial/Private
Labs
o
Public
Health Labs
·
Point
of Care (PoC) testing
Global STD
Diagnostics Testing Device Outlook (Revenue, USD Billion, 2012 - 2022)
·
Laboratory
Devices
o
Thermal
Cyclers - PCR
o
Lateral
Flow Readers – Immuno chromatographic assays
o
Flow
Cytometers
o
Differential
Light Scattering machines
o
Absorbance
micro plate reader - Enzyme Linked Immunosorbent Assay (ELISA)
o
Others
·
Point
of Care (PoC) Devices
o
Phone
chips (micro fluidics + ICT)
o
Portable/bench
top/rapid diagnostic kits
STD
Diagnostics Regional Outlook (Revenue, USD Billion, 2012 - 2022)
·
North
America
o
U.S.
o
Canada
·
Europe
o
Sweden
o
Germany
·
Asia
Pacific
o
China
o
India
·
Latin
America
o
Brazil
o
Mexico
·
MEA
o
South
Africa
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting services.
To help clients make informed business decisions, we offer market intelligence
studies ensuring relevant and fact-based research across a range of industries,
from technology to chemicals, materials and healthcare.
No comments:
Post a Comment